E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+
10X Capital Podcast
The 10X Capital podcast interviews the world's premier institutional investors to deliver insights on how they manage their capital. Interview topics include investment decision frameworks, capital allocation strategies, GP/LP relationships and many more.
Erik TorenbergDavid Weisburd
PodcastAI
PodcastAI

E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+

E37 • Jan 30, 2024 • 61 mins

Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company.

Key Points

  • The importance of pronoia, a mindset of believing that people are conspiring for your success rather than against you.
  • Approaches to biotech innovation involves creating a startup factory model that mitigates common industry risks by focusing on the unique 10% of each company.
  • Alloy Therapeutics aim to revolutionize drug discovery by leveraging shared infrastructure and reinvesting 100% of their revenue into continuous innovation and access.
Listen on Apple PodcastsListen on SpotifyListen on YouTube
- / -